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Post-traumatic stress disorder (PTSD) is a mental health
condition that occurs relatively commonly in people exposed
to situations that cause severe psychological stress, such as
natural disasters, combat, or physical attack. In this issue of
the Journal, Vaccarino et al. (1) report that the incidence of
coronary heart disease (CHD) was more than double in
twins from the Vietnam Era Twin (VET) Registry who had
PTSD compared with those without PTSD. Moreover, they
showed that PTSD was associated with signiﬁcantly lower
myocardial perfusion and coronary ﬂow reserve as assessed
by positron emission tomography.See page 970This study adds to the growing body of studies per-
formed in a variety of populations that show an association
between PTSD and clinical CHD. Some of these studies
show a dose relationship between the number of PTSD
symptoms and CHD (2,3). In addition, Ahmadi et al.
showed that PTSD was strongly associated with the pres-
ence and severity of coronary artery calciﬁcation, a measure
of subclinical atherosclerosis (4).
What underlies this relationship? PTSD is associated
with higher rates of cigarette smoking (5); may be associated
with other traditional cardiovascular disease risk factors
including hypertension, dyslipidemia, and diabetes (6); and
is also associated with newer risk factors such as biomarkers
of inﬂammation (7). Autonomic nervous system dysregula-
tion is also associated with PTSD, which can result in
reduced heart rate variability and increased QT variability
(8), both of which are predictors of adverse cardiovascular
outcomes.
Therefore, we have a great deal of data to support PTSD
as a risk factor for CHD and a number of potential mech-
anisms through which this risk is manifested. Indeed, in*Editorials published in the Journal of the American College of Cardiology reﬂect the
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results from the World Trade Center (WTC) Health
Registry study, stated that “the long-term follow-up of
the World Trade Center disaster victims and responders
provides an opportunity to quantify how...post traumatic
stress disorders may need to be factored into the FHS risk
score” (9). This editorial addressed a study in which PTSD
was associated with a 62% increased risk of heart disease in
men and a 68% increase in women (3). However, much like
the study by Vaccarino et al. (1), the baseline cardiovascular
risk factors (hypertension, diabetes) and study endpoints
(angina, heart attack, or any other heart condition) were
assessed by self-report of a physician diagnosis, and dysli-
pidemia/lipids was not included as a risk factor. Actual
measurement of the risk factors and validation of study
endpoints were not performed. This methodology inevitably
affects the precision of risk estimates because of the
imprecision of the risk factor and outcomes assessment. The
general issue is that many of the studies examining the
PTSD-CHD relationship have done so with less than
optimal self-reported risk factor data and with CHD
endpoints that were not validated, although exceptions do
exist (10).
Other considerations in examining the association of
PTSD with CHD and in designing future studies address-
ing this relationship include diagnostic criteria for PTSD,
duration and timing of exposure to PTSD, psychiatric
comorbidity, and pharmacological treatment. The diagnostic
criteria for PTSD have not been standardized across studies.
For example, 2 of the studies noted in this editorial used the
National Institute of Mental Health Diagnostic Interview
Schedule (1,2), while 3 of the studies used other validated
scales (3,4,10). It is common for studies to use different
measures in the assessment of exposure and is not necessarily
problematic but may contribute to some variability in results.
The impact of the duration and clinical course of PTSD
and the potential for pre-existing PTSD at the time of
assessment are other important study design issues. There
are differing trajectories of PTSD symptomatology that
ideally should be taken into account in assessing the risk of
CHD associated with PTSD, ranging from persistence of
high levels of symptomatology to complete resolution (11).
Because of this, the risk association of PTSD with CHD is
likely to be heterogeneous and partially dependent on the
trajectory.
In regard to the potential for pre-existing PTSD, studies
of PTSD and CHD risk are often performed to assess for
the presence of PTSD after an exposure that is associated
with PTSD, such as natural (e.g., earthquakes) or man-made
(e.g., terrorist attacks) disasters. Subjects from the pop-
ulations that are studied may have prior pre-existing PTSD
resulting from early exposure (e.g., exposure to assaultive
violence or death of a loved one). In these instances, the
onset of PTSD will predate the study assessment and might
affect the risk assessment because of the duration of the
disorder and the symptoms.
Sidney JACC Vol. 62, No. 11, 2013
PTSD and Coronary Heart Disease September 10, 2013:979–80
980Psychiatric comorbidities are frequently present in patients
with PTSD. For example, in the study by Vaccarino et al. (1),
major depression was present in 38% of study participants
with PTSD versus 19% without PTSD. Depression is an
established risk factor for CHD, but adjustment for depres-
sion does not generally have a signiﬁcant impact on the risk
estimates for PTSD. PTSD may be associated with other
psychotic disorders such as schizophrenia that are not gen-
erally considered in these analyses (12) and which themselves
may be associated with an increased risk of CHD (13).
Moreover, some antipsychotic medications are associated
with an increased risk of CHD (14).
Overall, there are considerable data supporting an asso-
ciation that is likely causal between PTSD and CHD
outcomes. Although the studies often use self-reported data
with risk factor measurement and self-reported outcomes
without validation, the strong associations with subclinical
outcomes (1,4), the studies that show a dose relationship,
and the evidence for plausible mechanistic associations
suggest that the relation is real and clinically important.
Because of the noted limitations of this and other studies,
calculation of a Framingham-type risk score including
PTSD for clinical CHD outcomes does not seem advisable
at this time. However, for the primary care physician or
cardiologist, the available data suggest a practical, common-
sense approach to the management of cardiovascular risk in
a patient who is at risk for or has a diagnosis of PTSD. A
patient who is at risk for PTSD (e.g., exposure to domestic
violence, assaultive violence, death of a loved one) should be
screened and a diagnosis should be obtained. If PTSD is
diagnosed, the patient should be treated by a clinician who
has expertise in the management of PTSD. The primary
care physician or cardiologist should manage more tradi-
tional risk factors (hyperlipidemia, hypertension, diabetes)
with lifestyle modiﬁcation and medication as appropriate
and should maintain awareness of the PTSD treatment plan,
particularly if it includes medications that may have an effect
on the occurrence of clinical cardiovascular events.
In conclusion, the study by Vaccarino et al. (1) and other
available data support an association between PTSD and
coronary disease that may be causal. The study by Vaccarino
et al. (1) is particularly important because of the powerful
association of PTSD with impaired myocardial coronary
perfusion assessed by positron emission tomography imag-
ing. Our consciousness should be raised to the importance of
obtaining a history of exposures that are associated with riskof PTSD and to perform or refer patients for screening,
diagnosis, and treatment when appropriate.Reprint requests and correspondence: Dr. Stephen Sidney, Divi-
sion of Research, Kaiser Permanente Northern California, 2000
Broadway, Oakland, California 94612. E-mail: steve.sidney@kp.org.REFERENCES
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